2018 annual financial data
Puma Biotechnology 2018 Operating margin
Puma Biotechnology 2018 operating margin with verified reported values.
Direct answer
Operating margin was -37.73%.
Operating income was -94,700,000 USD and net income was -113,600,000 USD.
Operating cash flow was -24,100,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 251,000,000 USD
- Operating income
- -94,700,000 USD
- Net income
- -113,600,000 USD
- Operating cash flow
- -24,100,000 USD